Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |